Published on in Vol 14 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/83839, first published .
Correction: Gamification of Incentive Spirometry in Trauma Patients: Protocol for a Prospective, Observational Feasibility Study

Correction: Gamification of Incentive Spirometry in Trauma Patients: Protocol for a Prospective, Observational Feasibility Study

Correction: Gamification of Incentive Spirometry in Trauma Patients: Protocol for a Prospective, Observational Feasibility Study

Corrigenda and Addenda

1Department of Neurology, Atrium Health Wake Forest Baptist Medical Center, Winston Salem, NC, United States

2Department of Surgery, College of Medicine, University of Oklahoma, Oklahoma, OK, United States

3Department of Surgery, Faculty of Medicine, Atrium Health Wake Forest Baptist Medical Center, Winston Salem, NC, United States

4Department of Intensive Care, Expertise Center for Intensive Care Rehabilitation, Apeldoorn Gelre Hospitals, Apeldoorn, The Netherlands

5Division of Neurocritical Care, Faculty of Medicine, Virginia Commonwealth University, Richmond, VA, United States

Corresponding Author:

Areen Al-Dhoon, MD

Department of Neurology

Atrium Health Wake Forest Baptist Medical Center

1 Medical Center Blvd

Winston Salem, NC, 27157

United States

Phone: 1 3364050740

Email: areendhoon@gmail.com



In “Gamification of Incentive Spirometry in Trauma Patients: Protocol for a Prospective, Observational Feasibility Study” (JMIR Res Protoc 2025;14(1):e75871) the authors made two clarifications.

The Results section in the Abstract has been changed from:

The study was approved by the institutional review board of Atrium Health Wake Forest Baptist Medical Center and was registered at ClinicalTrials.gov. However, no participants were ever enrolled, as the OmniFlow partners did not supply the device for the study. Despite this, it remains a potentially beneficial tool, and future studies may confirm its benefits once the device becomes available.

to

The study was approved by the institutional review board and registered on ClinicalTrials.gov. Due to an unexpected delay in the initiation of the project, no patients were enrolled.

The Results section in the main body of the paper has been changed from:

The study was approved by the institutional review board and registered on ClinicalTrials.gov. However, no participants were enrolled, as the OmniFlow devices were never delivered. Despite initial agreements, the device supplier became unresponsive and failed to fulfill the shipment. Multiple attempts to reestablish contact were unsuccessful. This unexpected barrier highlights the importance of reliable vendor partnerships when implementing novel therapeutic technologies in clinical research.

to

The study was approved by the institutional review board and registered on ClinicalTrials.gov. Due to an unexpected delay in the initiation of the project, no patients were enrolled.

This is a non–peer-reviewed article. submitted 09.Sep.2025; accepted 10.Sep.2025; published 26.Sep.2025.

Copyright

©Areen Al-Dhoon, Arthur Grimes, Carma Goldstein, Peter Spronk, R Shayn Martin, Aarti Sarwal. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 26.Sep.2025.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Research Protocols, is properly cited. The complete bibliographic information, a link to the original publication on https://www.researchprotocols.org, as well as this copyright and license information must be included.